Country: Vietnam
Bahasa: Vietnam
Sumber: BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)
Fluticasone furoate; Vilanterol (dưới dạng Vilanterol trifenatate)
GlaxoSmithKline Pte., Ltd.
Fluticasone furoate; Vilanterol (as Vilanterol trifenatate)
200mcg/1 liều chưa phóng thích; 25mcg/1 liều chưa phóng thích
Bột hít phân liều
Hộp chứa 1 dụng cụ 30 liều hít
Thuốc kê đơn
Glaxo Operations UK Ltd. (trading as Glaxo Wellcome Operations)
Tiêu Chuẩn: NSX; Tuổi Thọ: 24 tháng; Tá dược: Lactose monohydrate (chứa protein sữa); magnesi stearate
i l xfzs L P4v1c ^^sl Sticker of I ql PI I z //i) 5 a o * vAr,r pub oer olEru lRr r.p nA NG porterrO v rd cUc quaiv uf nr-roc PHE X}UYET .IJ6. DNNK: Carton PTE * I z o br'1 -\ ,i (! dt EN c l! o = E E o @ d c o E o o 6 a o = o c E ! o (, o E E o o '= e o o I F o z 6 E c o E , o ! .9 t z - F E 5 o ! .! c o 6 o d e o F o z o 6 o c a o c .9 E c = , o ,9 e 2 i, c .e This PDF has been ve rified using PitStop 12 PDF is PDF/X4 comoliant and GSK comrrliant for Cartons backino cards workflow Body text size: N/A Smallest text size: N/A Microtext: No TEXT SIZE CONTAINED IN THIS ARTWORK GlaxoSmithKline Artwork lnformation Panel VAN PHONG DAI DIEN TAI T.P HA ruol GSK Market is responsible for this product, its design and content. Ensure the artwork is thoroughly checked, all the text proof-read and approved. RSC GSK is responsible for site technical requirements and pre-press stuitability. \ Item Number: 10000000133677 Manufacturing Site: GSK-GBR-Ware-UKWAR Market or Pack Owner: Vietnam-VNM Market Trade Name: Relvar Ellipta Colour Standard Reference Number: N/A (do NOT indude tha teahni6l reference dfilsl veraion nolsl.) Technical Reference No(s).: JHA2301 Printing Process: N/A Substrate: N/A Total: 5 Tota!: 1 Total:0 Artwork copright is the property of the GlaxosmithKline 6roup of Companies All suppliers providing a serui(e to GsK for printed components of any description must ensure that they have a licence for all fonts / software used in conjunction with GSK artwork. The distribution and use of fonts / software without a licence (onstitutes an intellectual property infringement. GSK will not a((ept any liability for the breach of third party intellectual property rights by printed component suppliers. The GSK (ertifi(ation / audit pro(ess requires suppliers to de(lare that they do not use unlicensed fontr / software and may require the supplier to produ(e evidence of such li(ence to GSK. Formulation, Tablet embossing, Storage conditions, SpecialFinishes 288 2905 233 Varnishes lf Life IMPORTANT 2 Colours K ffi GSK Market i Baca dokumen lengkap